Paris - Delayed Quote • EUR
Quantum Genomics Société Anonyme (ALQGC.PA)
At close: April 26 at 5:25 PM GMT+2
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jean-Philippe Milon Ph.D. | CEO, MD & Chairman | 415.82k | -- | 1960 |
| Dr. Sarah Merlen-Boulenger | Head of Regulatory Affairs | -- | -- | -- |
Quantum Genomics Société Anonyme
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 3
Description
Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.
Corporate Governance
Quantum Genomics Société Anonyme’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Mar 13, 2024
Quantum Genomics Société Anonyme Earnings Call
Related Tickers
ALTHX.PA Theranexus Société Anonyme
1.1350
+1.34%
SIGHT.PA GenSight Biologics S.A.
0.4195
+0.36%
ALPHA.PA Pharnext SA
0.1499
-8.88%
DBV.PA DBV Technologies S.A.
1.1860
-1.17%
IF0.F InflaRx N.V.
1.2150
+1.50%
63E.F Onward Medical N.V.
4.3500
-2.68%
IPH.PA Innate Pharma S.A.
2.2450
+2.98%
BPTSY Biophytis S.A.
8.50
+3.41%
GNFT.PA Genfit S.A.
3.2100
+1.58%
OXUR.BR Oxurion NV
0.0001
0.00%